EUVIMEDEUVIMED entdecken
Crossref

The Association Between Longitudinal Changes in TRACP-5b and Bone Metastasis Progression During Osimertinib Therapy

Keisuke Ikegami, Reiko Ando Makihara, Yuki Shinno, Akiko Tateishi, Tomonori Mizutani, Yusuke Okuma, Tatsuya Yoshida, Hidehito Horinouchi, Noboru Yamamoto, Hironobu Hashimoto, Satoko Hori, Yasushi Goto

Anticancer Research · 2026

DOI: 10.21873/anticanres.18205 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2026. Verfasst von Keisuke Ikegami und 11 weiteren Autor:innen. Beteiligte Einrichtung: Keio University Faculty of Pharmacy, Graduate School of Pharmaceutical Sciences, Tokyo, Japan. Hauptthemen laut MEDLINE: Aniline Compounds, Bone Neoplasms, Acrylamides, Lung Neoplasms.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aniline CompoundsBone NeoplasmsAcrylamidesLung NeoplasmsTartrate-Resistant Acid PhosphataseCarcinoma, Non-Small-Cell LungHumansIndolesFemalePyrimidinesMaleDisease ProgressionAgedMiddle AgedRetrospective StudiesErbB ReceptorsMutationLongitudinal Studies

Stichwörter der Autor:innen

Non-small-cell lung carcinoma (NSCLC)bone metastasisdenosumabmixed-effects models for repeated measures (MMRM)osimertinibtartrate-resistant acid phosphatase 5b (TRACP-5b)

Substanzen

Aniline CompoundsIndolesosimertinibPyrimidinesAcrylamidesTartrate-Resistant Acid PhosphataseACP5 protein, humanErbB ReceptorsEGFR protein, human

Autor:innen und Institutionen

  • Keio University Faculty of Pharmacy, Graduate School of Pharmaceutical Sciences, Tokyo, Japan.
  • Department of Pharmacy, National Cancer Center Hospital, Tokyo, Japan; reando@ncc.go.jp.
  • Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Department of Pharmacy, National Cancer Center Hospital, Tokyo, Japan.

Zitieren

APA

Ikegami, K., Makihara, R. A., Shinno, Y., Tateishi, A., Mizutani, T., Okuma, Y., Yoshida, T., Horinouchi, H., Yamamoto, N., Hashimoto, H., Hori, S., & Goto, Y. (2026). The Association Between Longitudinal Changes in TRACP-5b and Bone Metastasis Progression During Osimertinib Therapy. Anticancer Research. https://doi.org/10.21873/anticanres.18205

Vancouver

Ikegami K, Makihara RA, Shinno Y, Tateishi A, Mizutani T, Okuma Y, et al. The Association Between Longitudinal Changes in TRACP-5b and Bone Metastasis Progression During Osimertinib Therapy. Anticancer Research. 2026. doi:10.21873/anticanres.18205

BibTeX
@article{Ikegami2026,
  author = {Ikegami, Keisuke and Makihara, Reiko Ando and Shinno, Yuki and Tateishi, Akiko and Mizutani, Tomonori and Okuma, Yusuke and Yoshida, Tatsuya and Horinouchi, Hidehito and Yamamoto, Noboru and Hashimoto, Hironobu and Hori, Satoko and Goto, Yasushi},
  title = {The Association Between Longitudinal Changes in TRACP-5b and Bone Metastasis Progression During Osimertinib Therapy},
  journal = {Anticancer Research},
  year = {2026},
  doi = {10.21873/anticanres.18205}
}
Kostenlos starten →